OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 122 filers reported holding OCULAR THERAPEUTIX INC in Q2 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $185,000 | -80.7% | 45,987 | -32.0% | 0.00% | -50.0% |
| Q2 2021 | $958,000 | -17.2% | 67,584 | -4.1% | 0.00% | -33.3% |
| Q1 2021 | $1,157,000 | -21.8% | 70,477 | -1.4% | 0.00% | -25.0% |
| Q4 2020 | $1,480,000 | +48.6% | 71,513 | -45.3% | 0.00% | +33.3% |
| Q3 2020 | $996,000 | -14.6% | 130,839 | -6.5% | 0.00% | -25.0% |
| Q2 2020 | $1,166,000 | +237.0% | 140,000 | +100.0% | 0.00% | +300.0% |
| Q1 2020 | $346,000 | -30.2% | 70,000 | +98.3% | 0.00% | -66.7% |
| Q3 2015 | $496,000 | -33.2% | 35,307 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $743,000 | -40.3% | 35,307 | +19.1% | 0.00% | -50.0% |
| Q1 2015 | $1,245,000 | – | 29,657 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 6,122,089 | $32,263 | 100.00% |
| Opaleye Management Inc. | 6,105,900 | $32,178,093 | 9.64% |
| DELTEC ASSET MANAGEMENT LLC | 1,913,612 | $10,084,735 | 2.49% |
| Knoll Capital Management, LLC | 200,000 | $1,504,000 | 2.32% |
| Endurant Capital Management LP | 512,744 | $2,702,161 | 1.39% |
| Knoll Capital Management, LLC | 95,800 | $504,866 | 0.78% |
| Covestor Ltd | 60,008 | $316 | 0.28% |
| Ikarian Capital, LLC | 200,000 | $1,054,000 | 0.24% |
| EAM Investors, LLC | 224,211 | $1,181,592 | 0.23% |
| Nebula Research & Development LLC | 22,474 | $118,438 | 0.21% |